Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint BlockadePaul Johannet, Wenke Liu, David Fenyo, et al.
Human Pathology|December 17, 2009
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarraysJanice M Mehnert, Mary M McCarthy, Lucia Jilaveanu, et al.
Gynecologic Oncology|December 8, 2018
Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028Andrea Varga, Sarina Piha-Paul, Patrick A Ott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivoAtif J Khan, Brian Wall, Stuti Ahlawat, et al.
British Journal of Cancer|July 30, 2019
Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanomaJason Chesney, Igor Puzanov, Frances Collichio, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 16, 2026
Systemic Therapies for the Treatment of Cutaneous Malignancies in Solid Organ Transplant RecipientsAkshay Pulavarty, Derek Maas, Archie Spindler, et al.
Investigational New Drugs|April 19, 2017
A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumorsJanice M Mehnert, Gerald Edelman, Mark Stein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
Immuno-oncology Clinical Trial Design: Limitations, Challenges, and OpportunitiesChristina S Baik, Eric H Rubin, Patrick M Forde, et al.
Cancer Research|February 5, 2014
Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progressionYu Wen, Jiadong Li, Jasmine Koo, et al.
Clinical Genitourinary Cancer|September 5, 2018
Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell CarcinomaMichael E Hurwitz, Paul Markowski, Xiaopan Yao, et al.
Pageof 9